HK1162616A1 - Methods for determining the risk of prenatal complications - Google Patents
Methods for determining the risk of prenatal complicationsInfo
- Publication number
- HK1162616A1 HK1162616A1 HK12103231.9A HK12103231A HK1162616A1 HK 1162616 A1 HK1162616 A1 HK 1162616A1 HK 12103231 A HK12103231 A HK 12103231A HK 1162616 A1 HK1162616 A1 HK 1162616A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- risk
- determining
- methods
- prenatal
- complications
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/515—Angiogenesic factors; Angiogenin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Physiology (AREA)
- Vascular Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2377608P | 2008-01-25 | 2008-01-25 | |
US2589008P | 2008-02-04 | 2008-02-04 | |
US6004808P | 2008-06-09 | 2008-06-09 | |
US6073208P | 2008-06-11 | 2008-06-11 | |
PCT/US2009/032062 WO2009094665A1 (fr) | 2008-01-25 | 2009-01-26 | Procédés de détermination du risque de complications prénatales |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1162616A1 true HK1162616A1 (en) | 2012-08-31 |
Family
ID=40901463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12103231.9A HK1162616A1 (en) | 2008-01-25 | 2012-04-02 | Methods for determining the risk of prenatal complications |
Country Status (9)
Country | Link |
---|---|
US (5) | US8647832B2 (fr) |
EP (3) | EP3109322A1 (fr) |
CN (2) | CN102216468B (fr) |
AU (1) | AU2009206243B2 (fr) |
CA (2) | CA2713229C (fr) |
ES (2) | ES2587077T3 (fr) |
HK (1) | HK1162616A1 (fr) |
PL (1) | PL2245180T3 (fr) |
WO (1) | WO2009094665A1 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002210403A1 (en) * | 2000-10-20 | 2002-04-29 | Como Biotech Aps | Pregnancy-associated plasma protein-a2 (papp-a2) |
CN102216468B (zh) * | 2008-01-25 | 2014-06-11 | 珀金埃尔默健康科学股份有限公司 | 确定产前并发症风险的方法 |
US8876714B2 (en) * | 2010-02-22 | 2014-11-04 | Wallac Oy | Systems and methods for assessing risk of chromosomal disorders |
US20120142559A1 (en) * | 2010-12-06 | 2012-06-07 | Pronota N.V. | Biomarkers and parameters for hypertensive disorders of pregnancy |
US20140349881A1 (en) * | 2011-12-15 | 2014-11-27 | Pronota N.V. | Biomarkers and parameters for preeclampsia |
CN104380104B (zh) * | 2012-04-24 | 2021-03-30 | 西门子医疗保健诊断公司 | 先兆子痫筛查法 |
EP2890816B1 (fr) * | 2012-08-30 | 2019-06-05 | Ansh Labs LLC | Papp-a2 en tant que marqueur pour la surveillance, la prédiction et le diagnostic de la prééclampsie |
US20140273025A1 (en) * | 2013-03-15 | 2014-09-18 | Wallac Oy | System and method for determining risk of pre-eclampsia based on biochemical marker analysis |
CN103207274B (zh) * | 2013-04-28 | 2015-02-25 | 成都中医药大学 | 一种胎儿7号染色体异常疾病的筛查试剂盒 |
CN103278633B (zh) * | 2013-04-28 | 2014-11-19 | 成都中医药大学 | 一种孕妇流产史筛查试剂盒 |
CN103235133B (zh) * | 2013-04-28 | 2014-11-19 | 成都中医药大学 | 一种胎儿9号染色体异常疾病的筛查试剂盒 |
CN103235142B (zh) * | 2013-04-28 | 2015-04-15 | 成都中医药大学 | 一种孕妇初次妊娠筛查试剂盒 |
US10183039B2 (en) | 2013-07-15 | 2019-01-22 | Vanderbilt University | Methods for the production of collagen IV |
WO2015148989A1 (fr) * | 2014-03-27 | 2015-10-01 | Wayne State University | Systèmes et méthodes pour identifier et traiter des sujets présentant un risque de complications obstétriques |
CN106662590A (zh) * | 2014-05-16 | 2017-05-10 | 塞尚公司 | 早期胎盘胰岛素样肽(pro‑EPIL) |
US10656163B2 (en) | 2014-09-02 | 2020-05-19 | Wallac Oy | Method for determining risk of pre-eclampsia |
WO2016042202A1 (fr) | 2014-09-17 | 2016-03-24 | Wallac Oy | Procédé pour déterminer le risque de naissance avant terme |
WO2016095789A1 (fr) * | 2014-12-15 | 2016-06-23 | The Chinese University Of Hong Kong | Détection de taxons bactériens pour la prédiction d'une naissance avant terme après une intervention clinique |
WO2016191793A1 (fr) | 2015-06-02 | 2016-12-08 | Medvet Science Pty Ltd | Procédés de dépistage de la trisomie fœtale |
KR101817180B1 (ko) * | 2016-01-20 | 2018-01-10 | 이원다이애그노믹스(주) | 염색체 이상 판단 방법 |
MX2020002788A (es) | 2017-09-13 | 2020-09-14 | Progenity Inc | Biomarcadores de preeclampsia y sistemas y metodos relacionados. |
EP4070113A4 (fr) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | Évaluation de la prééclampsie à l'aide de dosages du facteur de croissance placentaire libre et dissocié |
CN111370121A (zh) * | 2020-02-21 | 2020-07-03 | 杭州市妇产科医院 | 早孕期非整倍体产前筛查标志物预测妊娠期高血压疾病的风险模型建立方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9812432D0 (en) * | 1998-06-09 | 1998-08-05 | Queen Mary & Westfield College | Predictive test |
GB0026823D0 (en) * | 2000-11-02 | 2000-12-20 | King S College London | Diagnosis of pre-eclampsia |
US7407659B2 (en) * | 2002-07-19 | 2008-08-05 | Beth Israel Deaconess Medical Center | Methods of diagnosing pre-eclampsia or eclampsia |
US20050255114A1 (en) * | 2003-04-07 | 2005-11-17 | Nuvelo, Inc. | Methods and diagnosis for the treatment of preeclampsia |
GB0317476D0 (en) * | 2003-07-25 | 2003-08-27 | Wright David E | Methods and apparatus for screening for chromosomal abnormalities |
WO2006034427A2 (fr) * | 2004-09-20 | 2006-03-30 | Proteogenix, Inc. | Diagnostic d'aneuploidie foetale |
US7727733B2 (en) * | 2004-12-21 | 2010-06-01 | Yale University | Diagnosis of preeclampsia |
GB0600916D0 (en) * | 2006-01-17 | 2006-02-22 | Perkinelmer Instr Las Inc | detecting and predicting pre-eclampsia |
CN102216468B (zh) * | 2008-01-25 | 2014-06-11 | 珀金埃尔默健康科学股份有限公司 | 确定产前并发症风险的方法 |
-
2009
- 2009-01-26 CN CN200980110513.5A patent/CN102216468B/zh active Active
- 2009-01-26 EP EP16173417.3A patent/EP3109322A1/fr not_active Withdrawn
- 2009-01-26 PL PL09704269T patent/PL2245180T3/pl unknown
- 2009-01-26 EP EP09704269.1A patent/EP2245180B1/fr active Active
- 2009-01-26 CA CA2713229A patent/CA2713229C/fr active Active
- 2009-01-26 CN CN201410206612.6A patent/CN103969455B/zh active Active
- 2009-01-26 ES ES13177423.4T patent/ES2587077T3/es active Active
- 2009-01-26 AU AU2009206243A patent/AU2009206243B2/en active Active
- 2009-01-26 CA CA2967508A patent/CA2967508C/fr active Active
- 2009-01-26 ES ES09704269.1T patent/ES2523220T3/es active Active
- 2009-01-26 US US12/864,625 patent/US8647832B2/en active Active
- 2009-01-26 EP EP13177423.4A patent/EP2657697B1/fr active Active
- 2009-01-26 WO PCT/US2009/032062 patent/WO2009094665A1/fr active Application Filing
-
2012
- 2012-04-02 HK HK12103231.9A patent/HK1162616A1/xx unknown
-
2013
- 2013-07-18 US US13/945,143 patent/US8673582B2/en active Active
- 2013-12-31 US US14/144,687 patent/US20140113319A1/en not_active Abandoned
- 2013-12-31 US US14/144,740 patent/US8932823B2/en active Active
-
2015
- 2015-11-13 US US14/941,337 patent/US20160305950A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2657697A3 (fr) | 2014-02-19 |
US20140113320A1 (en) | 2014-04-24 |
US8647832B2 (en) | 2014-02-11 |
EP2245180A4 (fr) | 2011-06-08 |
EP2657697B1 (fr) | 2016-06-08 |
EP2245180B1 (fr) | 2014-06-18 |
CA2967508A1 (fr) | 2009-07-30 |
EP2657697A2 (fr) | 2013-10-30 |
CN103969455B (zh) | 2016-08-24 |
CA2713229A1 (fr) | 2009-07-30 |
CN102216468B (zh) | 2014-06-11 |
US8932823B2 (en) | 2015-01-13 |
CA2713229C (fr) | 2017-07-11 |
AU2009206243B2 (en) | 2014-10-02 |
AU2009206243A1 (en) | 2009-07-30 |
PL2245180T3 (pl) | 2015-03-31 |
WO2009094665A1 (fr) | 2009-07-30 |
CA2967508C (fr) | 2020-02-25 |
US20130344503A1 (en) | 2013-12-26 |
EP3109322A1 (fr) | 2016-12-28 |
US20160305950A1 (en) | 2016-10-20 |
EP2245180A1 (fr) | 2010-11-03 |
ES2587077T3 (es) | 2016-10-20 |
US8673582B2 (en) | 2014-03-18 |
US20140113319A1 (en) | 2014-04-24 |
US20100304412A1 (en) | 2010-12-02 |
ES2523220T3 (es) | 2014-11-24 |
CN102216468A (zh) | 2011-10-12 |
CN103969455A (zh) | 2014-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1162616A1 (en) | Methods for determining the risk of prenatal complications | |
ZA201101970B (en) | Multispecific antibodies | |
EP2359275A4 (fr) | Estimation d'une influence | |
EP2351777A4 (fr) | Anticorps anti-muc1 | |
HK1153538A1 (en) | Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1 | |
GB2462829B (en) | Measurement method | |
EP2147309A4 (fr) | Procédés de détection de la prééclampsie | |
GB2471221B (en) | Methods | |
EP2344667A4 (fr) | Méthodes de détermination d'haplotype par haplodissection | |
GB0818650D0 (en) | Methods | |
EP2389104A4 (fr) | Identification du niveau de risque foetal pendant le travail | |
EP2263086A4 (fr) | Biomarqueurs | |
EP2318508A4 (fr) | Détermination de l intégrité d arn | |
PL2183985T3 (pl) | Określanie ścieżki pochodzenia | |
EP2275814A4 (fr) | Procédé de mesure d'oligomère a | |
GB0811360D0 (en) | Methods | |
GB2457797B (en) | Covariance based face association | |
ZA201105184B (en) | Biomarker | |
EP2265641A4 (fr) | Biomarqueurs | |
EP2208986A4 (fr) | Procédé de détermination de l'auto-inducteur 2 | |
EP2340037A4 (fr) | Procédé de détermination des niveaux de tgf-bêta dans une composition | |
PL2288920T3 (pl) | Sposób określania zakażenia Trichinella | |
TWI348657B (en) | Determination method of edge direction | |
EP2231868A4 (fr) | Méthode de dosage | |
GB0819405D0 (en) | Assay method |